Patents by Inventor Anders Malmström

Anders Malmström has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150099703
    Abstract: The present invention refers to the use of certain sulfated glycosaminoglycans for treatment or prevention of postpartum haemorrhage. The sulfated glycosaminoglycans have a reduced anticoagulant activity and are administered in combination with at least one uterotonic agent capable of promoting myometrial contractions of the uterus and thereby compress the vessels and cease the bleeding.
    Type: Application
    Filed: May 7, 2013
    Publication date: April 9, 2015
    Inventors: Gunvor Ekman-Ordeberg, Anders Malmström
  • Publication number: 20150057226
    Abstract: The present invention refers to the use of certain sulfated glycosaminoglycans for treatment of labor arrest. The sulfated glycosaminoglycans have a reduced anticoagulant activity and are administered in combination with an agent capable of promoting myometrial contractions of the uterus and thereby re-establish effective labor.
    Type: Application
    Filed: March 25, 2013
    Publication date: February 26, 2015
    Inventors: Gunvor Ekman-Ordeberg, Anders Malmström
  • Publication number: 20150045322
    Abstract: The present invention refers to the use of certain sulfated glycosaminoglycans for inducing labor. The sulfated glycosaminoglycans have a reduced anticoagulant activity and are used in a combination therapy together with treatment capable of promoting cervical ripening or capable of promoting myometrial contractions of the uterus.
    Type: Application
    Filed: March 25, 2013
    Publication date: February 12, 2015
    Inventors: Gunvor EKMAN-ORDEBERG, Anders MALMSTRÖM
  • Patent number: 8524688
    Abstract: A method of treating protracted labor in a pregnant woman comprises administering to a pregnant woman an effective amount of a depolymerized low molecular weight heparin treated with periodate to eradicate antithrombin III binding affinities, thereby exhibiting an anticoagulant activity of 10 BP units/mg or less and an average molecular weight not higher than 10000 Da to prime or curatively treat the cervix and myometrium and for treatment of slow progress of labor. A method for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in a pregnant woman comprises administering to a pregnant woman an effective amount of a depolymerized low molecular weight heparin as described to prophylactically prime or curatively treat the cervix and myometrium and for establishing effective labor in the pregnant woman.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: September 3, 2013
    Assignee: Dilafor AB
    Inventors: Gunvor Ekman-Ordeberg, Anders Malmström
  • Publication number: 20120225843
    Abstract: A method of treating protracted labor in a pregnant woman comprises administering to a pregnant woman an effective amount of a depolymerised low molecular weight heparin treated with periodate to eradicate antithrombin III binding affinities, thereby exhibiting an anticoagulant activity of 10 BP units/mg or less and an average molecular weight not higher than 10000 Da to prime or curatively treat the cervix and myometrium and for treatment of slow progress of labor. A method for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in a pregnant woman comprises administering to a pregnant woman an effective amount of a depolymerised low molecular weight heparin as described to prophylactically prime or curatively treat the cervix and myometrium and for establishing effective labor in the pregnant woman.
    Type: Application
    Filed: May 9, 2012
    Publication date: September 6, 2012
    Applicant: DILAFOR AB
    Inventors: Gunvor EKMAN-ORDEBERG, Anders MALMSTRÖM
  • Patent number: 8207145
    Abstract: The invention refers to the use of sulfated glycosaminoglycans having an anticoagulant activity of 100 BP units/mg or less for the manufacture of a pharmaceutical preparation for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in women.
    Type: Grant
    Filed: July 7, 2008
    Date of Patent: June 26, 2012
    Assignee: Dilafor AB
    Inventors: Gunvor Ekman-Ordeberg, Anders Malmström
  • Patent number: 7407945
    Abstract: The invention refers to the use of sulfated glycosaminoglycans having an anticoagulant activity of 100 BP units/mg or less for the manufacture of a pharmaceutical preparation for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in women.
    Type: Grant
    Filed: January 2, 2003
    Date of Patent: August 5, 2008
    Assignee: Dilafor AB
    Inventors: Gunvor Ekman-Ordeberg, Anders Malmström